Education
About Us
Working with TipRanks
Follow Us
Xtant Medical Holdings Inc (XTNT)
:XTNT
Total Valuation
Xtant Medical Holdings has a market cap or net worth of $84.74M. The enterprise value is $139.83M.
Market Cap$84.74M
Enterprise Value$139.83M
Share Statistics
Xtant Medical Holdings has 130,315,720 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding130,315,720
Owned by Insiders10.02%
Owned by Institutions66.24%
Financial Efficiency
Xtant Medical Holdings’s return on equity (ROE) is -0.38 and return on invested capital (ROIC) is -15.47%.
Return on Equity (ROE)-0.38
Return on Assets (ROA)-0.18
Return on Invested Capital (ROIC)-15.47%
Return on Capital Employed (ROCE)-0.19
Revenue Per Employee540.40K
Profits Per Employee-75.80K
Employee Count217
Asset Turnover1.25
Inventory Turnover1.27
Valuation Ratios
The current PE Ratio of Xtant Medical Holdings is ―. Xtant Medical Holdings’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value1.38
Price to FCF―
Price to Operating Cash Flow60.27
PEG Ratio―
Income Statement
In the last 12 months, Xtant Medical Holdings had revenue of 117.27M and earned -16.45M in profits. Earnings per share was -0.12.
Revenue117.27M
Gross Profit68.22M
Operating Income-12.07M
Pretax Income-16.26M
Net Income-16.45M
EBITDA-7.88M
Earnings Per Share (EPS)-0.12
Cash Flow
In the last 12 months, operating cash flow was 1.50M and capital expenditures -4.33M, giving a free cash flow of -2.83M billion.
Operating Cash Flow1.50M
Free Cash Flow-2.83M
Free Cash Flow per Share-0.02
Dividends & Yields
Xtant Medical Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.29
52-Week Price Change4.84%
50-Day Moving Average0.63
200-Day Moving Average0.54
Relative Strength Index (RSI)55.06
Average Volume (3m)76.74K
Important Dates
Xtant Medical Holdings upcoming earnings date is Oct 30, 2025, After Close (Confirmed).
Last Earnings DateAug 12, 2025
Next Earnings DateOct 30, 2025
Ex-Dividend Date―
Financial Position
Xtant Medical Holdings as a current ratio of 2.35, with Debt / Equity ratio of 30.51%
Current Ratio2.35
Quick Ratio1.00
Debt to Market Cap0.59
Net Debt to EBITDA-3.67
Interest Coverage Ratio-2.90
Taxes
In the past 12 months, Xtant Medical Holdings has paid 187.00K in taxes.
Income Tax187.00K
Effective Tax Rate-0.01
Enterprise Valuation
Xtant Medical Holdings EV to EBITDA ratio is -11.19, with an EV/FCF ratio of -5.51.
EV to Sales0.75
EV to EBITDA-11.19
EV to Free Cash Flow-5.51
EV to Operating Cash Flow-7.41
Balance Sheet
Xtant Medical Holdings has $6.92M in cash and marketable securities with $14.80M in debt, giving a net cash position of $7.87M billion.
Cash & Marketable Securities$6.92M
Total Debt$14.80M
Net Cash$7.87M
Net Cash Per Share$0.06
Tangible Book Value Per Share$0.20
Margins
Gross margin is 60.16%, with operating margin of -10.30%, and net profit margin of -14.03%.
Gross Margin60.16%
Operating Margin-10.30%
Pretax Margin-13.87%
Net Profit Margin-14.03%
EBITDA Margin-6.72%
EBIT Margin-10.32%
Analyst Forecast
The average price target for Xtant Medical Holdings is $1.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$1.25
Price Target Upside92.31% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast15.16%
EPS Growth Forecast-39.18%